The kidney care system in the United States is expected to change, particularly with the implementation of the Kidney Care Choices (KCC) Model by the Centers for Medicare & Medicaid Services (CMS). This model was started to improve the management of patients with chronic kidney disease (CKD) stages 4 and 5 and End-Stage Renal Disease (ESRD). The KCC Model aims to provide coordinated care, reduce reliance on dialysis, and increase kidney transplant rates. It focuses on achieving better patient outcomes while managing rising healthcare costs related to kidney diseases.
The KCC Model has specific objectives. One of the primary goals is to decrease the number of patients who progress to kidney failure and need dialysis. As of 2016, nearly 430,000 Medicare recipients were undergoing treatment for ESRD, with about 88% of them relying on in-center hemodialysis as their main treatment. This data shows the need for alternative approaches that lessen the physical and financial strain on patients and the healthcare system.
To reach these goals, the KCC Model centers on several key elements:
The KCC Model operates under a performance period that began on January 1, 2022, and will end on December 31, 2026. During this time, there is an expectation of notable improvements in kidney care delivery:
A key expectation is a marked reduction in the number of patients needing dialysis. The KCC Model seeks to delay the onset of dialysis among CKD patients through better management practices and lifestyle changes. By supporting patients and integrating proactive care measures, healthcare providers can maintain kidney health before severe interventions are necessary.
Patients who receive education and coordinated care are expected to experience better health outcomes and improved quality of life. When patients understand their care, they are more likely to follow treatment recommendations, engage in lifestyle changes, and consider options such as kidney transplants.
The model’s emphasis on integrated care and financial incentives for providers might lead to improved health outcomes. Complications from CKD and ESRD may be better managed, resulting in fewer hospital visits and lower mortality rates in this patient population.
A significant goal of the CMS is to reduce overall healthcare spending in the United States. The KCC Model’s strategy is anticipated to lower costs tied to dialysis, hospitalizations, and other medical expenses through preventive care and increased transplant rates. Since the burden of ESRD costs Medicare billions each year, this model aims to create a more sustainable financial approach to kidney care.
Technology plays a vital role in supporting the KCC Model’s goals. Artificial Intelligence (AI) can improve patient care by streamlining processes and analyzing data, thus enhancing efficiency in healthcare settings. For medical administrators and staff, adopting AI tools can improve workflows and patient engagement.
Despite the promise of the KCC Model for kidney care, several challenges persist. Healthcare administrators and stakeholders should be ready to address these issues to achieve the desired benefits.
The KCC Model signifies a notable change in kidney care in the United States, with the potential to improve outcomes for individuals with CKD stages 4 and 5 and ESRD. While the goals are ambitious and the expected results are positive, challenges need to be addressed for effective implementation. The integration of technology, especially AI solutions, will be important for improving operations, care delivery, and patient engagement. As stakeholders adopt the KCC Model, the aim is to provide better care, assist patients, and ultimately lower healthcare costs. This transformation aims to manage kidney diseases more effectively and create a more sustainable future for the healthcare system.
The KCC Model is a program by the Centers for Medicare & Medicaid Services (CMS) designed to improve care for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) by offering coordinated care and financial incentives to healthcare providers.
The KCC Model aims to reduce kidney failure, decrease the number of patients requiring dialysis, and increase kidney transplants, ultimately enhancing patient quality of life and reducing healthcare costs.
The KCC Model includes four payment options: CMS Kidney Care First (KCF) Option, Comprehensive Kidney Care Contracting (CKCC) Graduated Option, CKCC Professional Option, and CKCC Global Option.
The KCF Option allows nephrology practices to receive adjusted capitation payments based on patient outcomes and quality measures while providing bonuses for successful kidney transplants.
KCEs are organizations under the CKCC options, which must include nephrology practices and transplant providers, and may also involve dialysis facilities and other providers.
Patient education is crucial in the KCC Model, aiming to empower patients to actively participate in their care and make informed decisions, thus enhancing treatment outcomes.
Beneficiaries eligible for alignment include Medicare patients with CKD stages 4 and 5, those on dialysis, and those who receive a kidney transplant, remaining aligned for three years post-transplant.
The CKCC options include distinct frameworks: Graduated (lower-risk), Professional (50% of shared savings/losses), and Global (100% risk for total cost of care) that define provider accountability.
The Implementation Period began in October 2020 to allow participants to build relationships and infrastructure, preceding the official performance period that started on January 1, 2022.
The KCC Model performance period began on January 1, 2022, and will continue through December 31, 2026, with updates and adjustments being made for sustainability.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
